Aino Health Valuation

AINO Stock  SEK 0.15  0.01  7.14%   
Aino Health seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Aino Health AB from analyzing the firm fundamentals such as Profit Margin of (0.75) %, current valuation of 64.25 M, and Return On Equity of -87.24 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
0.15
Please note that Aino Health's price fluctuation is out of control at this time. Calculation of the real value of Aino Health AB is based on 3 months time horizon. Increasing Aino Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Aino Health's intrinsic value may or may not be the same as its current market price of 0.15, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  0.15 Real  0.12 Hype  0.15
The intrinsic value of Aino Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Aino Health's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
0.12
Real Value
6.18
Upside
Estimating the potential upside or downside of Aino Health AB helps investors to forecast how Aino stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Aino Health more accurately as focusing exclusively on Aino Health's fundamentals will not take into account other important factors:
Hype
Prediction
LowEstimatedHigh
0.010.156.21
Details

Aino Health Total Value Analysis

Aino Health AB is presently anticipated to have takeover price of 64.25 M with market capitalization of 53.65 M, debt of 1.06 M, and cash on hands of 6.63 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Aino Health fundamentals before making investing decisions based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
64.25 M
53.65 M
1.06 M
6.63 M

Aino Health Investor Information

About 21.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.58. Aino Health AB had not issued any dividends in recent years. Based on the key indicators obtained from Aino Health's historical financial statements, Aino Health AB is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.

Aino Health Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Aino Health has an asset utilization ratio of 121.17 percent. This implies that the Company is making kr1.21 for each dollar of assets. An increasing asset utilization means that Aino Health AB is more efficient with each dollar of assets it utilizes for everyday operations.

Aino Health Ownership Allocation

Aino Health holds a total of 42.29 Million outstanding shares. Aino Health AB retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Aino Health Profitability Analysis

The company reported the revenue of 23.04 M. Net Loss for the year was (15.22 M) with loss before overhead, payroll, taxes, and interest of (591 K).

About Aino Health Valuation

The stock valuation mechanism determines Aino Health's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Aino Health AB based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Aino Health. We calculate exposure to Aino Health's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Aino Health's related companies.
Aino Health AB provides corporate health management solutions for private and public organizations in Finland. The company also provides health management business process outsourcing, as well as consulting services. Aino Health is traded on Stockholm Stock Exchange in Sweden.

8 Steps to conduct Aino Health's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Aino Health's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Aino Health's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Aino Health's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Aino Health's revenue streams: Identify Aino Health's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Aino Health's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Aino Health's growth potential: Evaluate Aino Health's management, business model, and growth potential.
  • Determine Aino Health's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Aino Health's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Additional Tools for Aino Stock Analysis

When running Aino Health's price analysis, check to measure Aino Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aino Health is operating at the current time. Most of Aino Health's value examination focuses on studying past and present price action to predict the probability of Aino Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aino Health's price. Additionally, you may evaluate how the addition of Aino Health to your portfolios can decrease your overall portfolio volatility.